During the past decade, Comprehensive Cancer Center at Wake Forest University conducted 136 clinical trials. In the 10-year time frame, 136 clinical trials started and 111 clinical trials were completed, i.e. on average, 81.6% percent of trials that started reached the finish line to date. In the past 5 years, 73 clinical trials started and 29 clinical trials were completed. i.e. 39.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Comprehensive Cancer Center at Wake Forest University" #1 sponsor was "Wake Forest University Health Sciences" with 199 trials, followed by "Alliance for Clinical Trials in Oncology" with 120 trials sponsored, "Gynecologic Oncology Group" with 60 trials sponsored, "Radiation Therapy Oncology Group" with 46 trials sponsored and "Children's Oncology Group" with 46 trials sponsored. Other sponsors include 161 different institutions and companies that sponsored additional 68 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Comprehensive Cancer Center at Wake Forest University" #1 collaborator was "National Cancer Institute (NCI)" with 544 trials as a collaborator, "Cancer and Leukemia Group B" with 18 trials as a collaborator, "SWOG Cancer Research Network" with 16 trials as a collaborator, "Eastern Cooperative Oncology Group" with 13 trials as a collaborator and "NRG Oncology" with 11 trials as a collaborator. Other collaborators include 118 different institutions and companies that were collaborators in the rest 94 trials.

According to Clinical.Site data, the most researched conditions in "Comprehensive Cancer Center at Wake Forest University" are "Leukemia" (64 trials), "Breast Cancer" (51 trials), "Lymphoma" (51 trials), "Lung Cancer" (45 trials) and "Brain and Central Nervous System Tumors" (41 trials). Many other conditions were trialed in "Comprehensive Cancer Center at Wake Forest University" in a lesser frequency.

Most popular intervention types in "Comprehensive Cancer Center at Wake Forest University" are "Drug" (418 trials), "Procedure" (164 trials), "Other" (141 trials), "Radiation" (140 trials) and "Biological" (125 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (91 trials), "cyclophosphamide" (53 trials), "cisplatin" (47 trials), "filgrastim" (44 trials) and "etoposide" (40 trials). Other intervention names were less common.

The vast majority of trials in "Comprehensive Cancer Center at Wake Forest University" are 479 trials for "All" genders, 120 trials for "Female" genders and 34 trials for "Male" genders.

Currently, there are NaN active trials in "Comprehensive Cancer Center at Wake Forest University". 1 are not yet recruiting, 50 are recruiting, 40 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 440 completed trials in Comprehensive Cancer Center at Wake Forest University, 1 suspended trials, and 77 terminated clinical trials to date.

Out of the total trials that were conducted in Comprehensive Cancer Center at Wake Forest University, 101 "Phase 1" clinical trials were conducted, 277 "Phase 2" clinical trials and 146 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 76 trials that are defined as “Not Applicable".